Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based company’s Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration
Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based companys Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration 510(k) clearance. The joint ventures partners would be located in New York City, Columbus, OH, and Knoxville, TN, and would be similar to other joint ventures currently in operation in sites such as Magee Womens Hospital and Englewood Hospital and Medical Center, according to Caprius.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.